Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Phase IV, Multicenter, International, Interventional Study to Evaluate the Effect of Diet on Gastrointestinal Adverse Events in Patients With IPF Treated With Pirfenidone

NCT03539289 is registered in ClinicalTrials.gov with Consorcio Centro de Investigación Biomédica en Red (CIBER) as lead sponsor.

NCT NCT03539289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03539289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Phase IV, Multicenter, International, Interventional Study to Evaluate the Effect of Diet on Gastrointestinal Adverse Events in Patients With IPF Treated With Pirfenidone
Lead sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase
Not applicable
Overall status
Completed
Start date
December 28, 2017
Completion date
April 22, 2020
Enrollment
90 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease